Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895536121> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2895536121 endingPage "23" @default.
- W2895536121 startingPage "17" @default.
- W2895536121 abstract "Double primary breast and esophageal cancer have been no reported cases in which treatment methods other than surgery were selected because of multiple metastasis or advanced cancer. The patient was a 52-year-old woman who had received left pectoral muscle-preserving mastectomy and axillary lymph node dissection (level 2) 7 years prior, following the diagnosis of left breast cancer. The postoperative diagnosis was pT2 N3a M0 stage IIIC and luminal human epidermal growth factor receptor 2 (HER2) phenotype. After the surgery, six courses of triple chemotherapy with 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide and four courses of docetaxel (DTX) were administered, and letrozole was administered for 5 years. Seven years after the surgery, swelling of her left axillary, supra-, and subclavicular lymph nodes, and sternum osteolysis were observed on computed tomography (CT). Radioisotope uptake was observed in the esophagus on positron emission tomography. An esophageal cancer was observed in the upper thoracic esophagus on esophagogastroscopy. The patient was administered a local treatment for esophageal cancer and systemic chemotherapy for both cancers. As a primary therapy, double chemotherapy with 5-FU and cisplatin (FP) (two courses) + radiotherapy on the esophagus and left supraclavicular lymph nodes (total target dose of radiotherapy was 60 Gy /30 fractions) was performed with the concomitant use of trastuzumab and zoledronate. Marked shrinkage [complete response (CR)] of the esophageal cancer was observed on esophagogastroscopy and shrinkage (partial response) of the left axillary and supra- and subclavicular lymph nodes were observed on CT. The secondary treatment included pertuzumab + trastuzumab + DTX. Bilateral pleural effusions were observed in the eighth course; therefore, DTX was withdrawn and the treatment was continued with only the molecularly targeted drugs. Two years have passed since the initiation of treatment. The individual lymph node metastatic foci have disappeared or markedly shrunk (CR) on CT scans and the sternal metastases have remained hard without change. In addition, CR for esophageal cancer has been maintained. We report a case of double primary recurrent HER2-positive breast cancer and esophageal cancer that responded well to radiotherapy and chemotherapy." @default.
- W2895536121 created "2018-10-12" @default.
- W2895536121 creator A5015255864 @default.
- W2895536121 creator A5020628793 @default.
- W2895536121 creator A5025661789 @default.
- W2895536121 creator A5042852320 @default.
- W2895536121 creator A5072526555 @default.
- W2895536121 creator A5074942490 @default.
- W2895536121 date "2018-10-01" @default.
- W2895536121 modified "2023-10-12" @default.
- W2895536121 title "Double primary recurrent human epidermal growth factor receptor 2-positive breast cancer and esophageal cancer that responded well to chemotherapy" @default.
- W2895536121 cites W1829957441 @default.
- W2895536121 cites W1999877389 @default.
- W2895536121 cites W2044182241 @default.
- W2895536121 cites W2117360256 @default.
- W2895536121 cites W2118683254 @default.
- W2895536121 cites W2126054851 @default.
- W2895536121 cites W2137228442 @default.
- W2895536121 cites W2146944629 @default.
- W2895536121 cites W2321846760 @default.
- W2895536121 cites W2396180273 @default.
- W2895536121 cites W2406189365 @default.
- W2895536121 cites W2407683521 @default.
- W2895536121 cites W2415785610 @default.
- W2895536121 cites W2439311978 @default.
- W2895536121 cites W2463853945 @default.
- W2895536121 cites W3213876936 @default.
- W2895536121 cites W4241929586 @default.
- W2895536121 cites W76228465 @default.
- W2895536121 doi "https://doi.org/10.1007/s13691-018-0347-9" @default.
- W2895536121 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6498216" @default.
- W2895536121 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31149541" @default.
- W2895536121 hasPublicationYear "2018" @default.
- W2895536121 type Work @default.
- W2895536121 sameAs 2895536121 @default.
- W2895536121 citedByCount "0" @default.
- W2895536121 crossrefType "journal-article" @default.
- W2895536121 hasAuthorship W2895536121A5015255864 @default.
- W2895536121 hasAuthorship W2895536121A5020628793 @default.
- W2895536121 hasAuthorship W2895536121A5025661789 @default.
- W2895536121 hasAuthorship W2895536121A5042852320 @default.
- W2895536121 hasAuthorship W2895536121A5072526555 @default.
- W2895536121 hasAuthorship W2895536121A5074942490 @default.
- W2895536121 hasBestOaLocation W28955361212 @default.
- W2895536121 hasConcept C121608353 @default.
- W2895536121 hasConcept C126322002 @default.
- W2895536121 hasConcept C126838900 @default.
- W2895536121 hasConcept C143998085 @default.
- W2895536121 hasConcept C2776694085 @default.
- W2895536121 hasConcept C2777649267 @default.
- W2895536121 hasConcept C2777819096 @default.
- W2895536121 hasConcept C2779223589 @default.
- W2895536121 hasConcept C2779742542 @default.
- W2895536121 hasConcept C2780835546 @default.
- W2895536121 hasConcept C2781190966 @default.
- W2895536121 hasConcept C509974204 @default.
- W2895536121 hasConcept C530470458 @default.
- W2895536121 hasConcept C71924100 @default.
- W2895536121 hasConceptScore W2895536121C121608353 @default.
- W2895536121 hasConceptScore W2895536121C126322002 @default.
- W2895536121 hasConceptScore W2895536121C126838900 @default.
- W2895536121 hasConceptScore W2895536121C143998085 @default.
- W2895536121 hasConceptScore W2895536121C2776694085 @default.
- W2895536121 hasConceptScore W2895536121C2777649267 @default.
- W2895536121 hasConceptScore W2895536121C2777819096 @default.
- W2895536121 hasConceptScore W2895536121C2779223589 @default.
- W2895536121 hasConceptScore W2895536121C2779742542 @default.
- W2895536121 hasConceptScore W2895536121C2780835546 @default.
- W2895536121 hasConceptScore W2895536121C2781190966 @default.
- W2895536121 hasConceptScore W2895536121C509974204 @default.
- W2895536121 hasConceptScore W2895536121C530470458 @default.
- W2895536121 hasConceptScore W2895536121C71924100 @default.
- W2895536121 hasIssue "1" @default.
- W2895536121 hasLocation W28955361211 @default.
- W2895536121 hasLocation W28955361212 @default.
- W2895536121 hasLocation W28955361213 @default.
- W2895536121 hasLocation W28955361214 @default.
- W2895536121 hasOpenAccess W2895536121 @default.
- W2895536121 hasPrimaryLocation W28955361211 @default.
- W2895536121 hasRelatedWork W1517291449 @default.
- W2895536121 hasRelatedWork W1966682194 @default.
- W2895536121 hasRelatedWork W2011286495 @default.
- W2895536121 hasRelatedWork W2048598228 @default.
- W2895536121 hasRelatedWork W2252510291 @default.
- W2895536121 hasRelatedWork W2361576180 @default.
- W2895536121 hasRelatedWork W2363888304 @default.
- W2895536121 hasRelatedWork W2403432050 @default.
- W2895536121 hasRelatedWork W3141931290 @default.
- W2895536121 hasRelatedWork W4246539674 @default.
- W2895536121 hasVolume "8" @default.
- W2895536121 isParatext "false" @default.
- W2895536121 isRetracted "false" @default.
- W2895536121 magId "2895536121" @default.
- W2895536121 workType "article" @default.